1/31
09:57 am
argx
Argenx SE – ADR (ARGX) Sentiments Bolstered on Vyvgart FDA Priority Review Milestone [Yahoo! Finance]
Low
Report
Argenx SE – ADR (ARGX) Sentiments Bolstered on Vyvgart FDA Priority Review Milestone [Yahoo! Finance]
1/30
02:18 am
argx
Argenx's (ARGX) Vyvgart Sales Outperform Expectations Across MG and CIDP Treatments [Yahoo! Finance]
Low
Report
Argenx's (ARGX) Vyvgart Sales Outperform Expectations Across MG and CIDP Treatments [Yahoo! Finance]
1/24
06:28 am
argx
argenex (NASDAQ:ARGX) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
Low
Report
argenex (NASDAQ:ARGX) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
1/23
05:06 am
argx
argenex (NASDAQ:ARGX) had its "hold (c)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
argenex (NASDAQ:ARGX) had its "hold (c)" rating reaffirmed by analysts at
Weiss Ratings.
1/20
11:01 am
argx
argenex (NASDAQ:ARGX) had its price target raised by analysts at Wells Fargo & Company from $1,264.00 to $1,317.00. They now have an "overweight" rating on the stock.
Low
Report
argenex (NASDAQ:ARGX) had its price target raised by analysts at Wells Fargo & Company from $1,264.00 to $1,317.00. They now have an "overweight" rating on the stock.
1/14
08:37 am
argx
argenex (NASDAQ:ARGX) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $1,000.00 price target on the stock.
Low
Report
argenex (NASDAQ:ARGX) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $1,000.00 price target on the stock.
1/13
01:00 am
argx
argenx Announces FDA Acceptance of Supplemental Biologics License Application with Priority Review for VYVGART in AChR-Ab Seronegative gMG
Low
Report
argenx Announces FDA Acceptance of Supplemental Biologics License Application with Priority Review for VYVGART in AChR-Ab Seronegative gMG
1/12
01:00 am
argx
argenx Highlights 2026 Strategic Priorities
Low
Report
argenx Highlights 2026 Strategic Priorities
1/8
03:25 pm
argx
argenex (NASDAQ:ARGX) had its price target lowered by analysts at Citigroup Inc. from $1,124.00 to $1,091.00. They now have a "buy" rating on the stock.
Low
Report
argenex (NASDAQ:ARGX) had its price target lowered by analysts at Citigroup Inc. from $1,124.00 to $1,091.00. They now have a "buy" rating on the stock.
1/8
12:49 pm
argx
argenex (NASDAQ:ARGX) had its price target raised by analysts at Truist Financial Corporation from $950.00 to $1,030.00. They now have a "buy" rating on the stock.
Low
Report
argenex (NASDAQ:ARGX) had its price target raised by analysts at Truist Financial Corporation from $950.00 to $1,030.00. They now have a "buy" rating on the stock.
1/6
01:00 am
argx
argenx to Present at 44th Annual J.P. Morgan Healthcare Conference
Low
Report
argenx to Present at 44th Annual J.P. Morgan Healthcare Conference
1/5
01:00 am
argx
argenx Announces Leadership Transition Marking Next Evolution of Growth
Medium
Report
argenx Announces Leadership Transition Marking Next Evolution of Growth
12/24
06:15 am
argx
argenex (NASDAQ:ARGX) was upgraded by analysts at DZ Bank AG to a "strong-buy" rating.
Low
Report
argenex (NASDAQ:ARGX) was upgraded by analysts at DZ Bank AG to a "strong-buy" rating.
12/19
05:57 am
argx
argenex (NASDAQ:ARGX) was downgraded by analysts at Baird R W from a "strong-buy" rating to a "hold" rating.
Low
Report
argenex (NASDAQ:ARGX) was downgraded by analysts at Baird R W from a "strong-buy" rating to a "hold" rating.
12/18
08:05 am
argx
argenex (NASDAQ:ARGX) had its "neutral" rating reaffirmed by analysts at Robert W. Baird. They now have a $858.00 price target on the stock, down previously from $924.00.
Low
Report
argenex (NASDAQ:ARGX) had its "neutral" rating reaffirmed by analysts at Robert W. Baird. They now have a $858.00 price target on the stock, down previously from $924.00.
12/17
10:23 am
argx
argenex (NASDAQ:ARGX) had its price target raised by analysts at Royal Bank Of Canada from $860.00 to $925.00. They now have an "outperform" rating on the stock.
Low
Report
argenex (NASDAQ:ARGX) had its price target raised by analysts at Royal Bank Of Canada from $860.00 to $925.00. They now have an "outperform" rating on the stock.
12/15
01:00 am
argx
argenx Provides Update on UplighTED Studies of Efgartigimod SC in Thyroid Eye Disease
Medium
Report
argenx Provides Update on UplighTED Studies of Efgartigimod SC in Thyroid Eye Disease
12/11
12:31 pm
argx
argenex (NASDAQ:ARGX) had its price target raised by analysts at Wells Fargo & Company from $1,095.00 to $1,316.00. They now have an "overweight" rating on the stock.
Low
Report
argenex (NASDAQ:ARGX) had its price target raised by analysts at Wells Fargo & Company from $1,095.00 to $1,316.00. They now have an "overweight" rating on the stock.
12/11
08:44 am
argx
argenex (NASDAQ:ARGX) had its price target raised by analysts at Stifel Nicolaus from $1,028.00 to $1,248.00. They now have a "buy" rating on the stock.
Low
Report
argenex (NASDAQ:ARGX) had its price target raised by analysts at Stifel Nicolaus from $1,028.00 to $1,248.00. They now have a "buy" rating on the stock.
12/8
11:03 am
argx
argenex (NASDAQ:ARGX) had its price target raised by analysts at JPMorgan Chase & Co. from $925.00 to $1,100.00. They now have an "overweight" rating on the stock.
Low
Report
argenex (NASDAQ:ARGX) had its price target raised by analysts at JPMorgan Chase & Co. from $925.00 to $1,100.00. They now have an "overweight" rating on the stock.
12/4
10:11 am
argx
argenex (NASDAQ:ARGX) had its price target raised by analysts at Morgan Stanley from $1,070.00 to $1,110.00. They now have an "overweight" rating on the stock.
Low
Report
argenex (NASDAQ:ARGX) had its price target raised by analysts at Morgan Stanley from $1,070.00 to $1,110.00. They now have an "overweight" rating on the stock.
11/24
08:06 am
argx
argenex (NASDAQ:ARGX) had its "peer perform" rating reaffirmed by analysts at Wolfe Research.
Low
Report
argenex (NASDAQ:ARGX) had its "peer perform" rating reaffirmed by analysts at Wolfe Research.
11/18
04:01 pm
argx
argenx Announces Results of Extraordinary General Meeting of Shareholders
Low
Report
argenx Announces Results of Extraordinary General Meeting of Shareholders
11/17
10:23 am
argx
argenex (NASDAQ:ARGX) had its price target raised by analysts at Citigroup Inc. from $1,041.00 to $1,124.00. They now have a "buy" rating on the stock.
Low
Report
argenex (NASDAQ:ARGX) had its price target raised by analysts at Citigroup Inc. from $1,041.00 to $1,124.00. They now have a "buy" rating on the stock.
11/14
10:32 am
argx
argenex (NASDAQ:ARGX) had its price target raised by analysts at Wedbush from $880.00 to $1,000.00. They now have an "outperform" rating on the stock.
Low
Report
argenex (NASDAQ:ARGX) had its price target raised by analysts at Wedbush from $880.00 to $1,000.00. They now have an "outperform" rating on the stock.